📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Nureca Promoters' Stake Rises to 68.09% Following Share Buyback Extinguishment
Nureca Limited's promoter group has seen their collective shareholding increase from 64.97% to 68.09%. This change is a direct result of the company's recent buyback program, which concluded with the extinguishment of 4,58,255 equity shares on January 07, 2026. While the absolute number of shares held by the promoters remained unchanged at 64,97,176, the reduction in the total share capital base led to a 3.12% increase in their voting rights. This transaction is exempt from open offer requirements under SEBI (SAST) Regulation 10(4)(c).
Key Highlights
Promoter group stake increased by 3.12% to reach a total of 68.09% of the company.
Total equity share capital reduced from 1,00,00,175 to 95,41,920 shares post-extinguishment.
A total of 4,58,255 shares, representing approximately 4.58% of the pre-buyback capital, were extinguished.
Individual promoter Saurabh Goyal's stake increased from 32.17% to 33.72% without purchasing new shares.
The disclosure was filed under Regulation 10(6) of SEBI (SAST) Regulations, 2011.
💼 Action for Investors
The increase in promoter stake via buyback is a positive signal of management's confidence in the company's valuation. Investors should look for improvements in Earnings Per Share (EPS) as a result of the reduced share count in future financial reports.
Nureca Q3 FY26: PAT Surges 233% YoY to ₹3.7 Cr; Revenue Up 27% to ₹54 Cr
Nureca Limited reported a strong financial performance for Q3 FY26, with revenue growing 27% YoY to INR 540 Mn. The company achieved a significant turnaround in profitability, posting a PAT of INR 37 Mn compared to a loss of INR 28 Mn in the same quarter last year. EBITDA saw a massive 314% YoY jump to INR 54 Mn, reflecting improved operational efficiency and a 10% margin. The company remains debt-free and continues to derive over 90% of its revenue from digital channels, supported by a cumulative customer base of 17.5 million.
Key Highlights
Q3 FY26 Revenue grew 27% YoY to INR 540 Mn; 9M FY26 revenue reached INR 1,536 Mn.
PAT turned positive at INR 37 Mn in Q3 FY26, a 233% increase from a loss of INR 28 Mn in Q3 FY25.
EBITDA for Q3 FY26 stood at INR 54 Mn (10% margin) compared to INR 25.4 Mn in the previous year.
The company is debt-free with a healthy current ratio of 9.6 and a cumulative customer base of 17.5 million.
Digital-first strategy remains dominant with over 90% of revenue generated through online sales.
💼 Action for Investors
Investors should take note of the significant turnaround in profitability and the company's successful transition to a higher-margin, asset-light model. Monitor the progress of the delayed Punjab manufacturing site and the monetization of the 'Dr Trust 360' app as future growth drivers.
Nureca Reports Q3 FY26 Revenue Growth of 27% YoY and PAT Turnaround to INR 37 Mn
Nureca Limited reported a strong Q3 FY26 with revenue increasing 27% YoY to INR 540 Mn and a significant turnaround in profitability, posting a PAT of INR 37 Mn compared to a loss in the previous year. The company continues to dominate the digital healthcare space with over 90% of revenue generated through online sales and a cumulative customer base of 17.5 million. EBITDA grew substantially to INR 54 Mn, reflecting a 113% increase over the previous year's quarter. The company remains debt-free with a healthy liquidity position, although its new manufacturing site in Punjab faces delays due to statutory approvals.
Key Highlights
Revenue for Q3 FY26 grew 27% YoY to INR 540 Mn, while 9M FY26 revenue reached INR 1,536 Mn.
Achieved a PAT of INR 37 Mn in Q3 FY26, a sharp recovery from a loss of INR 28 Mn in Q3 FY25.
Gross Profit surged 50% YoY to INR 396 Mn, driven by strong brand equity of 'Dr Trust' and digital-first efficiency.
Maintains a debt-free balance sheet with a cumulative customer base of 17.5 million users.
New manufacturing facility at Sundran, Punjab is currently delayed pending statutory approvals.
💼 Action for Investors
Investors should view the turnaround to profitability and strong revenue growth as a positive sign of operational efficiency. Monitor the progress of the Punjab manufacturing facility and the company's ability to scale its 'Dr Trust 360' connected health ecosystem.
Nureca Q3 FY26 Results: Revenue Up 50% YoY, PAT Turns Positive at ₹3.7 Cr
Nureca Limited reported a strong Q3 FY26 with revenue rising 50% YoY to ₹39.6 crore. The company successfully turned around its bottom line, posting a PAT of ₹3.7 crore against a loss of ₹2.8 crore in Q3 FY25. For the 9M FY26 period, revenue grew 43% to ₹111.6 crore, and PAT surged 604% to ₹8.2 crore. This performance was driven by sourcing efficiencies, cost optimization, and improved manufacturing capabilities.
Key Highlights
Q3 FY26 Revenue grew 50% YoY to ₹39.6 crore compared to ₹26.5 crore in Q3 FY25
Operating profit for Q3 FY26 stood at ₹3.3 crore, a 181% recovery from a loss of ₹4.0 crore
9M FY26 PAT increased by 604% YoY to ₹8.2 crore from a loss of ₹1.6 crore
Sequential revenue growth was 5% QoQ, indicating steady momentum
Management highlights cost optimization and supply chain controls as key margin drivers
💼 Action for Investors
Nureca has demonstrated a sharp recovery in profitability and strong top-line growth. Investors should watch for the sustainability of these margins as the company scales its manufacturing and sourcing operations.
Nureca Q3FY26 Results: Consolidated PAT Rises 33% to ₹37.3M; Revenue Up 57% YoY
Nureca Limited reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue from operations growing 57.3% YoY to ₹416.22 million. The company's consolidated profit after tax increased to ₹37.34 million from ₹28.01 million in the same quarter last year. On a standalone basis, the company achieved a significant turnaround, posting a profit of ₹32.31 million compared to a loss of ₹32.89 million in Q3FY25. Additionally, the company successfully completed a share buyback worth ₹19.14 crore at ₹330 per share during the quarter.
Key Highlights
Consolidated revenue from operations surged 57.3% YoY to ₹416.22 million in Q3FY26.
Consolidated PAT grew by 33.3% YoY to ₹37.34 million, with EPS rising to ₹3.91 from ₹2.80.
Standalone results showed a major turnaround with a profit of ₹32.31 million vs a loss of ₹32.89 million YoY.
Completed a ₹19.14 crore buyback at ₹330 per share, resulting in the extinguishment of shares during the quarter.
Ongoing merger with subsidiary Nureca Technologies Private Limited is set for an effective date of April 1, 2025.
💼 Action for Investors
The strong revenue growth and turnaround in standalone profitability indicate improving operational efficiency and demand. Investors should monitor the progress of the subsidiary merger and the impact of the reduced share capital on future EPS.
Nureca Q3 FY26 Consolidated PAT Rises 33% YoY to ₹3.73 Cr; Revenue Up 39% YoY
Nureca Limited reported a strong performance for Q3 FY26, with consolidated revenue from operations growing 39.3% YoY to ₹39.64 crore. Net profit for the quarter stood at ₹3.73 crore, a significant improvement from ₹2.80 crore in the same period last year. For the nine-month period, the company turned profitable with a PAT of ₹8.16 crore compared to a loss of ₹1.62 crore in 9M FY25. Additionally, the company successfully completed a share buyback worth ₹19.14 crore at ₹330 per share during the quarter.
Key Highlights
Consolidated Revenue from operations increased to ₹39.64 crore in Q3 FY26 from ₹28.46 crore in Q3 FY25.
Net Profit (PAT) grew 33.3% YoY to ₹3.73 crore, with EPS rising to ₹3.91 from ₹2.80.
9M FY26 performance showed a sharp turnaround with a profit of ₹8.16 crore vs a loss of ₹1.62 crore in the previous year.
Successfully completed a buyback of equity shares worth ₹19.14 crore at a price of ₹330 per share.
Ongoing merger process of wholly-owned subsidiary Nureca Technologies Private Limited to streamline operations.
💼 Action for Investors
The company shows strong signs of a turnaround and operational efficiency, having moved from losses to consistent profits. Investors should monitor the progress of the subsidiary merger and the impact of the reduced share capital following the buyback on future EPS.
Nureca Completes Extinguishment of 4.58 Lakh Shares Following ₹330/Share Buyback
Nureca Limited has successfully completed the extinguishment of 4,58,255 equity shares following its buyback via the tender offer route. The buyback was executed at a price of ₹330 per share, leading to a reduction in the total paid-up equity share capital by approximately 4.58%. Post-extinguishment, the total number of equity shares stands reduced at 95,41,920 from the previous 1,00,00,175 shares. This corporate action is now fully concluded in compliance with SEBI Buyback Regulations.
Key Highlights
Extinguished 4,58,255 equity shares of face value ₹10 each on January 7, 2026.
The buyback was conducted at a price of ₹330 per share through a tender offer mechanism.
Total paid-up equity share capital decreased from ₹10.00 crore to ₹9.54 crore.
The total number of outstanding equity shares reduced from 1,00,00,175 to 95,41,920.
The buyback tendering period was open from December 18, 2025, to December 24, 2025.
💼 Action for Investors
The reduction in the total share base is expected to be EPS-accretive for existing shareholders. Investors should look for improved return on equity (ROE) in upcoming financial statements due to the reduced capital base.
Nureca Receives Warning Letters from BSE and NSE for Regulatory Non-Compliance
Nureca Limited has been issued formal warning letters by both BSE and NSE for failing to comply with SEBI (Listing Obligations and Disclosure Requirements) Regulations. The company did not conduct any meeting of its Stakeholders Relationship Committee during the entire Financial Year 2024-25, violating Regulation 20(3A). While the company reports no immediate financial impact, the exchanges have warned that future lapses will be viewed seriously and could lead to further disciplinary action. The board is now required to review these warnings and implement corrective measures to ensure future compliance.
Key Highlights
Received warning letters from BSE on January 06, 2026, and NSE on January 07, 2026.
Non-compliance identified regarding Regulation 20(3A) of SEBI LODR for FY 2024-25.
Zero meetings of the Stakeholders Relationship Committee were held during the specified financial year.
Exchanges have advised the company to exercise due caution and initiate corrective steps immediately.
Company states there is no quantifiable monetary impact on financial or operational activities currently.
💼 Action for Investors
Investors should treat this as a red flag regarding the company's internal governance and compliance oversight. While there is no immediate fine, continued regulatory lapses could lead to stricter penalties or impact investor sentiment.
Nureca Limited Completes ₹19.14 Crore Share Buyback at ₹330 Per Share
Nureca Limited has issued a post-buyback public announcement following the completion of its share repurchase program via the tender offer route. The company bought back equity shares for an aggregate amount not exceeding ₹19.14 crores at a maximum price of ₹330 per share. The buyback process, managed by Mefcom Capital Markets Limited, followed the board's approval on November 28, 2025. This announcement marks the formal conclusion of the buyback exercise as per SEBI regulations.
Key Highlights
Maximum buyback size of ₹19,14,00,000 (₹19.14 crores) excluding transaction costs.
Buyback price set at a maximum of ₹330 per equity share with a face value of ₹10.
The offer was executed through the tender offer mechanism via the stock exchange.
Post-buyback public announcement was published on January 01, 2026, in major national newspapers.
Mefcom Capital Markets Limited acted as the Manager to the Buyback Offer.
💼 Action for Investors
Investors who participated in the tender offer should verify the credit of funds in their bank accounts. The reduction in equity capital post-buyback may marginally improve the company's Earnings Per Share (EPS) for remaining shareholders.
Nureca Limited Announces Buyback of Shares not exceeding ₹19.14 Crore
Nureca Limited has announced a buyback of its equity shares for an aggregate amount not exceeding ₹19,14,00,000. The buyback will be executed through a tender offer via the stock exchange mechanism, in accordance with SEBI regulations and the Companies Act. The maximum buyback price is set at ₹330.00 per equity share, payable in cash. Mefcom Capital Markets Limited has been appointed as the merchant banker to manage the buyback process.
Key Highlights
Buyback size not exceeding ₹19,14,00,000
Maximum Buyback Price of ₹330.00 per Equity Share
Face value of ₹ 10/- per equity share
Buyback approved on November 28, 2025
💼 Action for Investors
Shareholders should review the public announcement for detailed information about the buyback, including the process and timeline. Consider consulting with a financial advisor to determine whether to participate in the tender offer.